Table III.
Univariate and multivariate Cox analyses of overall survival of patients with non-small cell lung cancer.
Univariate Cox analysis of survival | Multivariate Cox analysis of survival | |||||||
---|---|---|---|---|---|---|---|---|
Characteristics | P-value | Hazard ratio | 95% CI lower | 95% CI upper | P-value | Hazard ratio | 95% CI lower | 95% CI upper |
p63 (negative vs. positive) | 0.7645 | 1.0680 | 0.6945 | 1.6424 | ||||
TTF-1 (negative vs. positive) | 0.8613 | 1.0484 | 0.6168 | 1.7822 | ||||
Histological type (adeno vs. SCC) | 0.1486 | 0.7301 | 0.4765 | 1.1187 | ||||
Clinical stage (I–II vs. III–IV) | 0.0003 | 1.5542 | 1.2215 | 1.9775 | 0.6312 | 1.1109 | 0.7231 | 1.7064 |
pT (pT1-2 vs. pT3-4) | 0.0024 | 1.5170 | 1.1593 | 1.9852 | 0.0061 | 1.7928 | 1.1809 | 2.7216 |
pN (pN0 vs. pN1-3) | 0.0023 | 1.9072 | 1.2604 | 2.8861 | 0.0068 | 1.4608 | 1.1105 | 1.9216 |
Necrosis (%) (continuous) | 0.3824 | 0.9458 | 0.8347 | 1.0718 | ||||
Histological grade (G1 vs. G2-3) | 0.1886 | 1.3095 | 0.8761 | 1.9572 | ||||
Tesmin IRS (0 vs. 1–12) | 0.1184 | 3.0555 | 0.7521 | 12.4124 | ||||
Tesmin nuclear (0 vs. 1–4) | 0.3831 | 1.2978 | 0.7225 | 2.3310 | ||||
MCM-5 (0–2 vs. 3–4) | 0.4159 | 0.8169 | 0.5019 | 1.3297 | ||||
MCM-7 (0–2 vs. 3–4) | 0.5114 | 1.3192 | 0.5770 | 3.0160 | ||||
Ki-67 (0–2 vs. 3–4) | 0.8906 | 0.9641 | 0.5730 | 1.6224 |
IRS, immunoreactive score; MCM, minichromosome maintenance protein; TTF-1, thyroid transcription factor 1; SCC, squamous cell carcinoma of the lung.